
India’s health-technology ecosystem is rapidly maturing beyond consumer apps. In 2024–2025 there’s a clear shift toward supply-side innovation: device manufacturing, AI-enabled clinical workflows, and hospital system integrations rooted in India.
According to Tracxn, 39+ new healthtech startups were founded in the first half of 2025, and Bain & Company reports roughly 30% of healthtech VC now flows into MedTech and diagnostics rather than pure telemedicine. Combined with Make-in-India incentives and faster IVD approvals, startups are building localized, exportable care-delivery ecosystems optimized for India’s needs.
From online pharmacies to AI-driven diagnostics, innovative health tech companies are transforming patient care. Leading platforms like PharmEasy, Tata 1mg and MediBuddy dominate the digital health space, while AI-powered ventures (Qure.ai, Niramai) and wellness brands (HealthifyMe, cult.fit) serve specialized needs.
Traditional hospital chains (Apollo Hospitals, Max Healthcare) and pharma giants (Sun Pharma, Dr. Reddy’s) remain top healthcare companies in India[1]. But ventures following agile methodology now capture significant markets and funding. The table below summarizes the main categories and example startups:
| No. | Startup Name | Category | Headquarters | Funding Raised | Notable Investors |
|---|---|---|---|---|---|
| 1 | Netmeds | Online Pharmacy | Chennai | US$ 99 M | Daun Penh Cambodia Group, Sistema Asia Capital, OrbiMed |
| 2 | Tata 1mg | Online Pharmacy | Gurugram | US$ 240 M | Tata Digital |
| 3 | PharmEasy | Online Pharmacy | Mumbai | US$ 1.1 B | Temasek, Prosus Ventures |
| 4 | Practo | Telemedicine Platform | Bengaluru | US$ 232 M | Sequoia Capital, Tencent |
| 5 | MediBuddy | E-Health Platform | Bengaluru | US$ 160 M | Quadria Capital |
| 6 | Qure.ai | AI Diagnostics | Mumbai | US$ 87 M | Novo Holdings, MassMutual Ventures |
| 7 | Niramai | AI Diagnostics | Bengaluru | US$ 30 M | Pi Ventures, Axilor Ventures |
| 8 | SigTuple | AI Pathology | Bengaluru | US$ 30 M | Accel, Chiratae Ventures |
| 9 | Tricog Health | AI Cardiology | Bengaluru | US$ 25 M | Inventus Capital |
| 10 | HealthifyMe | Wellness & Fitness | Bengaluru | US$ 100 M | LeapFrog Investments, Khosla Ventures |
| 11 | Cult.fit | Fitness Tech | Bengaluru | US$ 650 M | Accel, Temasek |
| 12 | BeatO | Chronic Care / Diabetes | Delhi | US$ 33 M | Orios Venture Partners |
| 13 | Sugar.fit | Diabetes Management | Bengaluru | US$ 10 M | Cure.fit, Tanglin Ventures |
| 14 | Plum Health | Health Insurance & Wellness | Bengaluru | US$ 65 M | Tiger Global |
| 15 | Wellthy Therapeutics | Chronic Disease Management | Mumbai | US$ 8 M | Saama Capital |
| 16 | Innovaccer | Healthcare IT / Data | Noida | US$ 375 M | Tiger Global, Mubadala |
| 17 | HealthPlix | EMR / IT Platform | Bengaluru | US$ 23 M | Lightspeed Ventures, JSW Ventures |
| 18 | MFine | Telemedicine Platform | Bengaluru | US$ 95 M | BEENEXT, SBI Investment |
| 19 | Dozee | MedTech / Patient Monitoring | Bengaluru | US$ 15 M | Prime Venture Partners |
| 20 | Forus Health | MedTech / Ophthalmic Devices | Bengaluru | US$ 10 M | Accel Partners |
Digital pharmacies and e-health platforms have emerged as vital infrastructure in India’s healthcare mix. They combine last-mile logistics, prescription digitisation and remote consultations to reach beyond major urban centres. Adoption of online consults, remote monitoring and e-pharmacies is booming. The domestic digital health market (telehealth, mobile health apps, EHR) is projected to grow at ~18% CAGR, reaching ₹4.1 lakh Cr ($47.8B) by 2033[2].
Website: www.pharmeasy.in[3]
Address: Mumbai, Maharashtra
Employee Size: ~2,000+
Funding Raised: US$ 1.1 B
Investors: Temasek, Prosus Ventures, TPG Growth
About: PharmEasy is an integrated digital health marketplace providing medicine delivery, diagnostic test bookings, and teleconsultations. The platform aggregates a network of pharmacies and diagnostics labs, enabling home-sample collection and doorstep delivery across urban and semi-urban India. PharmEasy focuses on reducing access friction by combining logistics, prescription digitization, and retail pharmacy partnerships to service millions of customers and support subscription and enterprise health packages.
USP: PharmEasy’s distinctive strength lies in its large-scale logistics and acquisition-driven growth model that integrates pharmacies, diagnostics, and telehealth into one user journey. By consolidating supply networks and offering bundled health packages plus insurance tie-ups, PharmEasy drives high customer retention and price efficiencies. Its ability to scale last-mile delivery and integrate lab and medicine workflows reduces time-to-care and eases system burdens on physical hospitals and clinics.
Website: www.1mg.com[4]
Address: Gurugram, Haryana
Employee Size: 1,000+
Funding Raised: US$ 240 M
Investors: Tata Digital
About: Tata 1mg (formerly 1mg) is a comprehensive digital health service offering e-pharmacy, lab test bookings, and doctor consultations. The platform aggregates medicine listings, provides prescription management, and connects users to diagnostic centres and clinicians. Leveraging Tata Group’s enterprise strengths, Tata 1mg aims to extend reach into semi-urban and rural markets with integrated digital health records and partnerships that align with national health initiatives like the Ayushman Bharat Digital Mission.
USP: Backed by Tata Digital, Tata 1mg benefits from strong brand trust, supply-chain capital and enterprise distribution channels. Its unique differentiator is an end-to-end, enterprise-grade platform combining retail pharmacy logistics with clinical and diagnostic integrations-enabling smoother interoperability with hospital systems and national health stacks. This scale and institutional backing allow Tata 1mg to deliver competitive pricing and rapid regional expansion.
Website: www.netmeds.com[5]
Address: Chennai, Tamil Nadu
Employee Size: ~500
Funding Raised: US$ 99 M
Investors: Daun Penh Cambodia Group, Sistema Asia Capital, OrbiMed
About: Netmeds operates an online pharmacy platform connecting customers to licensed pharmacists, prescription fulfillment, and health products across thousands of PIN codes. The company digitises handwritten prescriptions, coordinates with local pharmacy partners, and handles last-mile delivery for OTC and prescription medicines. Netmeds places emphasis on reliability, regulatory compliance, and availability across tier-2 and tier-3 markets.
USP: Netmeds’ advantage is its deep penetration into non-metro regions via strong pharmacy partner networks and effective prescription digitisation. By integrating local pharmacies into an online marketplace, Netmeds maintains supply continuity while offering transparent pricing and medicine authenticity assurances. Its trust positioning and regional logistics footprint enable it to serve areas often neglected by larger retail chains.
Website: www.practo.com[6]
Address: Bengaluru, Karnataka
Employee Size: ~800
Funding Raised: US$ 232 M
Investors: Sequoia Capital India, Tencent Holdings
About: Practo began as a doctor search and appointment platform and has evolved into a comprehensive telemedicine and practice-management ecosystem. The platform enables video consultations, appointment scheduling, prescriptions, and patient health-record storage. In addition to consumer services, Practo provides clinic and hospital software tools to manage workflows, billing, and patient follow-ups across a broad network of clinicians. Practo reported its first profitable fiscal year in FY2025 (EBITDA positive on ₹234 Cr revenue)[7]
USP: Practo’s dual focus on patient-facing services and provider workflows gives it a unique network effect: a large clinician base attracts patients, while practice-management tools improve provider loyalty. Its integrated data and appointment systems streamline continuity of care, reduce administrative overhead for clinics, and improve adherence through digital reminders and record keeping—helping both patients and providers manage long-term care journeys.
Website: www.medibuddy.in[8]
Address: Bengaluru, Karnataka
Employee Size: ~900
Funding Raised: US$ 160 M
Investors: Quadria Capital, Lightrock India
About: MediBuddy provides a digital health platform that bundles teleconsultations, home lab sample collection, medicine delivery, and corporate wellness solutions. Serving individual consumers and enterprise clients, it coordinates clinical telehealth services with diagnostic logistics and medication fulfilment. MediBuddy also powers employee healthcare programs and preventive-health initiatives for corporates looking to reduce absenteeism and insurance costs.
USP: MediBuddy’s core differentiator is its enterprise-centric approach combined with consumer convenience: by operating both B2B (corporate health) and B2C channels, it generates diversified revenue while scaling diagnostics and telehealth. The platform’s integrated workflow for remote diagnostics and medicine fulfilment improves employee health engagement and delivers measurable reductions in healthcare spend for corporate customers.
Artificial intelligence is transforming diagnostics and hospital operations. Startups like Qure.ai, SigTuple and Tricog are automating image and lab analyses, while companies like HEAPS Health (a recent AI analytics platform) improve hospital efficiency. In 2025, investors have funded analytics and EMR platforms (Innovaccer, HealthPlix) signaling a push toward data-driven healthcare[9]
Website: www.qure.ai[10]
Address: Mumbai, Maharashtra
Employee Size: ~300
Funding Raised: US$ 87 M
Investors: Novo Holdings, MassMutual Ventures
About: Qure.ai builds AI models that analyse radiology images—X-rays, CT scans, and more-to detect conditions such as tuberculosis, stroke, and pulmonary diseases. The company’s solutions perform triage, flag critical cases, and provide automated reports to radiologists and clinicians. Qure.ai targets hospitals and public-health programmes, offering tools to speed diagnostics and expand imaging access in resource-constrained settings.
USP: Qure.ai’s differentiator is clinically validated deep-learning models trained on millions of scans and deployed at scale across hospitals and national programmes. Its ability to deliver rapid, high-accuracy triage and integrate into PACS and hospital workflows reduces diagnostic bottlenecks and improves early detection—especially valuable in regions with few radiologists and high imaging demand.
Website: www.niramai.com[11]
Address: Bengaluru, Karnataka
Employee Size: ~150
Funding Raised: US$ 30 M
Investors: Pi Ventures, Axilor Ventures
About: Niramai uses thermal-sensing combined with machine-learning to detect early signs of breast cancer in a non-invasive, radiation-free manner. Its solution consists of a portable screening device and an AI algorithm that analyses thermal patterns to flag suspicious tissue changes. Niramai focuses on affordable, stigma-free screening suitable for community camps, primary care centres, and workplace health checks in low-resource settings.
USP: Niramai’s unique value is in delivering contact-less, affordable early screening without radiation—enabling broader community adoption and repeat screening. By addressing cultural and logistical barriers with a portable, privacy-preserving test, Niramai increases screening rates among underserved women, improving early detection and potentially reducing late-stage interventions and mortality.
Website: www.sigtuple.com[12]
Address: Bengaluru, Karnataka
Employee Size: ~200
Funding Raised: US$ 30 M
Investors: Accel, Chiratae Ventures
About: SigTuple develops AI-powered smart microscopes and cloud-based analytics to automate blood, urine, and pathology slide interpretation[13]. The platform digitises microscopy, applies machine-vision algorithms to identify anomalies, and generates consistent lab reports to assist pathologists. SigTuple’s approach improves throughput for diagnostic labs and supports rural sample collection with centralised analysis.
USP: SigTuple’s core advantage is automating repetitive pathology tasks to reduce turnaround time and human error while scaling lab capacity. By combining hardware and cloud AI, it allows labs to process higher volumes with consistent quality, enabling broader diagnostic coverage and cost efficiencies. Backed by Top VC Firms of India this startup is rocking the waters of healthcare industry.
Website: www.tricog.com[14]
Address: Bengaluru, Karnataka
Employee Size: ~250
Funding Raised: US$ 25 M
Investors: Inventus Capital Partners
About: Tricog Health offers AI-driven ECG and cardiac imaging interpretation services that enable rapid remote cardiac diagnosis. Hospitals and diagnostic centres upload ECGs and ultrasound data to Tricog’s cloud platform, where algorithms and cardiologists analyse results and return fast, actionable reports. The service supports emergent decision-making and cardiac triage across hospitals and smaller clinics.
USP: Tricog’s value proposition is near real-time cardiac reads powered by validated AI and clinical oversight, enabling faster diagnosis even in hospitals without in-house cardiologists. This capability shortens time to treatment for critical cardiac events, improves outcomes in remote settings, and supports large-scale screening efforts with consistent interpretation and clinical escalation pathways.
Health and fitness tech startups are enabling personalised wellness at scale through AI-powered nutrition plans, workout tracking, gamification and hybrid delivery models. These companies reflect a shift in focus from treatment to prevention, and from episodic to continuous engagement in health.
Website: www.healthifyme.com[15]
Address: Bengaluru, Karnataka
Employee Size: ~400
Funding Raised: US$ 100 M
Investors: LeapFrog Investments, Khosla Ventures
About: HealthifyMe is an AI-driven nutrition and fitness platform offering personalised diet plans, coaching, calorie tracking, and health analytics. Its virtual coach “Ria” uses user data to give real-time suggestions while human coaches provide deeper guidance. HealthifyMe serves millions of users in India and overseas, focusing on weight management, diabetes prevention, and lifestyle change interventions.
USP: HealthifyMe’s strength is its AI-plus-human coaching hybrid model, which scales personalised interventions while retaining behavioural nuance through human coaches. The platform’s strong dataset and adaptive coaching improve adherence and measurable outcomes like weight and glycaemic control—making it a leading preventive health solution that bridges digital convenience with human accountability.
Website: www.cult.fit[16]
Address: Bengaluru, Karnataka
Employee Size: ~1,500
Funding Raised: US$ 650 M
Investors: Accel, Temasek Holdings
About: Cult.fit operates a hybrid wellness ecosystem combining physical fitness centers, digital workouts, nutrition planning, and mental health offerings. Users can attend in-person classes or access on-demand sessions via the app, with additional services for meal plans and mental wellness. Cult.fit targets consumers seeking integrated fitness-and-wellness experiences across urban India.
USP: Cult.fit differentiates via a full-stack wellness model - blending brick-and-mortar classes with strong digital delivery and nutrition/mental health services. Its omnichannel approach increases engagement and retention by meeting users where they are (online or offline), while corporate wellness tie-ups and subscription models provide steady revenues and high lifetime value.
India’s rising chronic-disease burden means startups focusing on long-term management, prevention and insurance-enabled health services are gaining significance. Digital platforms that monitor, coach and engage patients over time are reshaping how care is delivered post-diagnosis.
Website: www.beato.com[17]
Address: New Delhi, Delhi
Employee Size: ~350
Funding Raised: US$ 33 M
Investors: Orios Venture Partners
About: BeatO provides an integrated diabetes management platform combining smart glucometers, a mobile app for glucose tracking, virtual coaching, and medicine delivery. The system allows patients to log readings, access personalized coaching, and order supplies via the app. BeatO focuses on improving glycaemic control and reducing emergency events through continuous engagement and remote monitoring.
USP: BeatO’s distinctive offering is a hardware-plus-platform model that fuses affordable glucometers with persistent behavioural coaching and medication logistics. This full-stack approach supports continuous patient engagement, enabling better glucose management and fewer complications. By simplifying data capture and linking it to coaching and supply chains, BeatO reduces friction in chronic-care adherence.
Website: www.sugar.fit[18]
Address: Bengaluru, Karnataka
Employee Size: ~200
Funding Raised: US$ 10 M
Investors: Cure.fit, Tanglin Ventures
About: Sugar.fit offers diabetes reversal and management programs that blend continuous glucose monitoring (CGM), personalized coaching, nutrition planning, and fitness routines. Its services target pre-diabetes and type-2 diabetes populations seeking lifestyle-driven improvement. Sugar.fit uses data from wearables and coach interactions to tailor interventions aimed at reducing medication dependence and improving metabolic health.
USP: Sugar.fit stands out by combining CGM data with structured lifestyle programs to pursue diabetes reversal rather than solely symptom control. The emphasis on data-driven personalization and demonstrable metabolic improvements enables measurable clinical outcomes, appealing to motivated users and providers seeking non-pharmacologic pathways for chronic disease management.
Website: www.plumhq.com/health[19]
Address: Bengaluru, Karnataka
Employee Size: ~320
Funding Raised: US$ 65 M
Investors: Tiger Global Management
About: Plum Health, part of insurance and employee benefits platform Plum, provides digital health insurance, wellness programs, and preventive care services to startups and SMEs.
Originally an insurtech (Bengaluru, founded 2018) focused on corporate health insurance. Plum launched Plum Health (₹200 Cr investment[20]) to provide preventive care services (diagnostics, teleconsults, AI tracking) for employees. The Tiger Global–backed firm raised $15 M in 2021 to build this full-stack healthcare arm.
USP: Plum Health’s differentiation is its combination of insurance administration with proactive wellness interventions-delivering both cost containment and health improvement for small and medium employers. By simplifying claims and incentivizing preventive care, Plum Health helps employers reduce long-term health liabilities while improving workforce productivity.
Check out: Complete guide on how to start a startup
Website: www.wellthy.com[21]
Address: Mumbai, Maharashtra
Employee Size: ~150
Funding Raised: US$ 8 M
Investors: Saama Capital
About: Wellthy Therapeutics develops digital therapeutics and behaviour-change programs for chronic diseases including diabetes, cardiovascular conditions, and obesity. Their mobile-first interventions combine evidence-based modules, coaching workflows, and clinician dashboards to improve medication adherence, lifestyle changes, and clinical outcomes. Wellthy primarily supports long-term condition management via scalable digital programs deployed with payers and providers.
USP: Wellthy’s unique value is in translating behavioural science into scalable digital therapeutics that demonstrate clinical outcomes and adherence improvements. By combining structured interventions with clinician oversight and data analytics, Wellthy enables measurable disease-management improvements that can be integrated into insurer and hospital workflows—achieving sustained patient behaviour change rather than episodic care.
As hospitals, clinics and governments digitise operations and data, there is growing demand for platforms that manage records, unify analytics and support provider workflows. These startups are building foundational infrastructure for the broader healthtech ecosystem
Website: www.innovaccer.com[22]
Address: Noida, Uttar Pradesh
Employee Size: ~700
Funding Raised: US$ 375 M
Investors: Tiger Global, Mubadala Investment
About: Innovaccer offers a healthcare data platform that unifies electronic health records, payer data, lab results, and patient flows into a single analytic layer for hospitals and health systems. Its Healthcare Intelligence Cloud enables care-gap identification, population health analytics, and operational optimisation. Innovaccer targets health systems transitioning to value-based care models and seeking data driven efficiency.
USP: Innovaccer’s competitive edge is its ability to ingest disparate datasets and operationalise analytics for clinical and administrative decision-making. By enabling provider networks to close care gaps and monitor outcomes at scale, Innovaccer helps shift organisations from volume to value—delivering measurable cost savings and better patient outcomes through unified data intelligence.
Website: www.healthplix.com[23]
Address: Bengaluru, Karnataka
Employee Size: ~250
Funding Raised: US$ 23 M
Investors: Lightspeed Ventures, JSW Ventures
About: HealthPlix builds EMR and clinic-management software tailored for Indian physicians and small hospitals. The platform streamlines patient records, prescriptions, follow-ups, and billing through mobile and web interfaces. HealthPlix focuses on usability and clinical decision support to help primary care doctors and specialists reduce administrative burden and improve continuity of care.
USP: HealthPlix excels in delivering clinician-centric EMR workflows adapted to Indian practice patterns—reducing documentation time and improving diagnostic consistency. Its design prioritises quick adoption by busy physicians, offering integrated decision support and follow-up reminders that enhance care continuity and adherence without imposing heavy technical overhead.
Website: www.mfine.co[24]
Address: Bengaluru, Karnataka
Employee Size: ~650
Funding Raised: US$ 95 M
Investors: BEENEXT, SBI Investment
About: MFine is an AI-powered telemedicine platform that enables instant consultations with doctors from partner hospitals, alongside home lab testing and medicine delivery. It integrates triage, consultation, diagnosis, and prescription fulfilment in one workflow. MFine partners with hospital networks to extend clinical services digitally, providing continuity of care and remote monitoring capabilities.
USP: MFine’s strength is its hospital-partnership model combined with AI triage to match patients to the right specialists quickly. This integration improves care coordination and reduces the friction of specialist access. By embedding digital services inside hospital ecosystems, MFine supports continuity of clinical records and leverages provider capacity more efficiently.
India’s MedTech and public-health segment is increasingly innovative, moving from medtech import dependence toward domestic manufacturing and solutions tailored to Indian use-cases. These startups build devices, monitoring systems and rural-health models that scale beyond major metros. Supported by government manufacturing incentives and “make in India” policies, they are becoming exporters, not just consumers
Website: www.dozee.health[25]
Address: Bengaluru, Karnataka
Employee Size: ~180
Funding Raised: US$ 15 M
Investors: Prime Venture Partners
About: Dozee develops contactless, AI-powered patient monitoring systems that track vitals like heart rate, respiration, and sleep using bedside sensors. Devices feed continuous data into dashboards that alert clinicians to anomalies and enable remote home monitoring. Dozee targets hospitals and home-care markets to improve early detection of deterioration and support post-acute monitoring.
USP: Dozee’s non-intrusive monitoring technology allows continuous vital tracking without wearables, reducing nurse burden and enabling scalable post-discharge care. Its predictive alerting and analytics help catch clinical deterioration earlier, lowering readmission risk and enabling safer transitions from hospital to home—critical in resource-constrained settings where continuous staffing is limited.
Website: www.forushealth.com[26]
Address: Bengaluru, Karnataka
Employee Size: ~220
Funding Raised: US$ 10 M
Investors: Accel Partners
About: Forus Health develops affordable ophthalmic screening devices-such as portable retinal cameras—and deploys them in camps, clinics, and rural centres to enable early detection of retinal disease and blindness risk. Devices connect to cloud platforms for image analysis and tele-ophthalmology workflows. Forus focuses on scalable eye-care screening in low-resource settings to reduce preventable vision loss.
USP: Forus combines low-cost hardware with cloud analytics to democratise eye screening at the community level. Its portability and ease of use let non-specialist health workers perform screenings and transmit images for remote review, expanding early detection in places without ophthalmologists. This model reduces avoidable blindness through timely referrals and decentralised screening.
India’s healthtech market is maturing from consumer telehealth and e-pharmacy into a broader innovation ecosystem: AI diagnostics, MedTech manufacturing Parks, healthcare data platforms, and chronic-care programs are attracting capital and policy support. Government initiatives (Ayushman Bharat Digital Mission, PLI for medical devices, Startup India) and manufacturing incentives underpin a local supply base that’s increasingly export-capable. Startups that tightly integrate clinical workflows, regulatory strategy, and community deployment models stand to scale fastest.
India’s government has significantly ramped support for healthtech and MedTech innovation to prevent medtech startups from failing. Key initiatives include:
India’s healthtech startup ecosystem is evolving from beginnings of telemedicine and e-pharmacy toward a robust innovation pipeline that spans diagnostics, chronic-care platforms, wellness-tech and MedTech manufacturing. With government infrastructure, funding momentum and clinical demand aligning, startups have an unprecedented opportunity to scale and impact millions in India and beyond.
At GrowthJockey, we specialise in growth strategies for health-tech enterprises - helping connect startups with marketing, SEO, user-acquisition and care-delivery partners. The next decade will favour those who build reproducible, patient-centric and data-driven models, and we’re here to help you navigate that journey.
Q1: Who is the biggest healthcare company in India?
Large hospital chains like Apollo Hospitals and major pharma players such as Sun Pharma are among the largest by revenue and reach; in digital health, companies like PharmEasy and Tata 1mg are the largest startups by funding and user base.
Q2: What are the top 3 trends in Indian healthcare?
AI-driven diagnostics and automation; preventive and chronic-care platforms; and a shift toward domestic MedTech manufacturing supported by government incentives.
Q3: Which startup is most successful in India?
Success depends on metrics-by scale and funding, PharmEasy and Tata 1mg lead; for AI diagnostics, Qure.ai and SigTuple have strong global traction.
Q4: How to start a healthcare startup in India?
Identify a validated clinical problem, pilot with providers, comply early with regulations, partner with hospitals/labs, and design revenue models (B2B/B2C) that scale.
Q5: What is the easiest healthcare business to start?
Digital consult platforms, wellness coaching, or health content/e-commerce have lower capital requirements than device manufacturing or hospital chains.